The antigen-specific memory CD8+ T-cell response induced by BCG in cattle resides in the CD8+γ/δTCR-CD45RO+ T-cell population

Vaccine

Volumn 27, Issue 2, 2009, Pages 270-279

  Hogg, Alison E ^a   Worth, Andrew ^b   Beverley, Peter ^b   Howard, Christopher J ^a   Villarreal Ramos, Bernardo ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b EDWARD JENNER INST FOR VACC RES   (United Kingdom)

Author keywords

CD8+ T cells; Memory; Tuberculosis

Indexed keywords

BCG VACCINE; CD45RO ANTIGEN; GAMMA INTERFERON; PERFORIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CATTLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNE RESPONSE; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MALE; MEMORY CELL; MYCOBACTERIUM; MYCOBACTERIUM BOVIS; NONHUMAN; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION; UPREGULATION; VACCINATION;

ANIMALS; ANTIGENS; ANTIGENS, BACTERIAL; ANTIGENS, CD45; BCG VACCINE; CATTLE; CD8-POSITIVE T-LYMPHOCYTES; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM BOVIS; PERFORIN; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; TUBERCULOSIS, BOVINE;

EID: 57149119052     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.10.053     Document Type: Article

References (55)

1. WHO. WHO report 2008 global tuberculosis control surveillance, planning, financing. Geneva: World Health Organization; 2008.
2. Calmette A. Preventive Vaccination against tuberculosis with BCG. Proc R Soc Med 24 September (11) (1931) 1481-1490
3. Fine P.E. Bacille Calmette-Guerin vaccines: a rough guide. Clin Infect Dis 20 January (1) (1995) 11-14
4. Brewer T.F. Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature. Clin Infect Dis 31 September (Suppl 3) (2000) S64-S67
5. Colditz G.A., Brewer T.F., Berkey C.S., Wilson M.E., Burdick E., Fineberg H.V., et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271 March (9) (1994) 698-702
6. Hewinson R.G., Vordermeier H.M., and Buddle B.M. Use of the bovine model of tuberculosis for the development of improved vaccines and diagnostics. Tuberculosis 83 1-3 (2003) 119-130
7. Behar S.M., Dascher C.C., Grusby M.J., Wang C.R., and Brenner M.B. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J Exp Med 189 June (12) (1999) 1973-1980
8. Palmieri F., Pellicelli A.M., Girardi E., De Felici A.P., De Mori P., Petrosillo N., et al. Negative predictors of survival in HIV-infected patients with culture-confirmed pulmonary tuberculosis. Infection 27 November-December (6) (1999) 331-334
9. Murray J., Sonnenberg P., Shearer S.C., and Godfrey-Faussett P. Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients. Am J Respir Crit Care Med 159 March (3) (1999) 733-740
10. Shafer R.W., Bloch A.B., Larkin C., Vasudavan V., Seligman S., Dehovitz J.D., et al. Predictors of survival in HIV-infected tuberculosis patients. AIDS 10 March (3) (1996) 269-272
11. Flynn J.L. Immunology of tuberculosis and implications in vaccine development. Tuberculosis (Edinb) 84 1-2 (2004) 93-101
12. Canaday D.H., Wilkinson R.J., Li Q., Harding C.V., Silver R.F., and Boom W.H. CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism. J Immunol 167 September (5) (2001) 2734-2742
13. De La Barrera S.S., Finiasz M., Frias A., Aleman M., Barrionuevo P., Fink S., et al. Specific lytic activity against mycobacterial antigens is inversely correlated with the severity of tuberculosis. Clin Exp Immunol 132 June (3) (2003) 450-461
14. Mutis T., Cornelisse Y.E., and Ottenhoff T.H. Mycobacteria induce CD4+ T cells that are cytotoxic and display Th1- like cytokine secretion profile: heterogeneity in cytotoxic activity and cytokine secretion levels. Eur J Immunol 23 9 (1993) 2189-2195
15. Serbina N.V., Lazarevic V., and Flynn J.L. CD4(+) T cells are required for the development of cytotoxic CD8(+) T cells during mycobacterium tuberculosis infection. J Immunol 167 12 (2001) 6991-7000
16. Endsley J.J., Hogg A., Shell L.J., McAulay M., Coffey T., Howard C., et al. Mycobacterium bovis BCG vaccination induces memory CD4+ T cells characterized by effector biomarker expression and anti-mycobacterial activity. Vaccine 25 50 (2007) 8384-8394
17. Flynn J.L., Goldstein M.M., Triebold K.J., Koller B., and Bloom B.R. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 89 24 (1992) 12013-12017
18. Sousa A.O., Mazzaccaro R.J., Russell R.G., Lee F.K., Turner O.C., Hong S., et al. Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. Proc Natl Acad Sci USA 97 8 (2000) 4204-4208
19. Tascon R.E., Stavropoulos E., Lukacs K.V., and Colston M.J. Protection against Mycobacterium tuberculosis infection by CD8+ T cells requires the production of gamma interferon. Infect Immun 66 2 (1998) 830-834
20. Wang J., Santosuosso M., Ngai P., Zganiacz A., and Xing Z. Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells. J Immunol 173 October (7) (2004) 4590-4597
21. Turner J., D'Souza C.D., Pearl J.E., Marietta P., Noel M., Frank A.A., et al. CD8- and CD95/95L-dependent mechanisms of resistance in mice with chronic pulmonary tuberculosis. Am J Respir Cell Mol Biol 24 February (2) (2001) 203-209
22. Smith S.M., Brookes R., Klein M.R., Malin A.S., Lukey P.T., King A.S., et al. Human CD8+ CTL specific for the mycobacterial major secreted antigen 85A. J Immunol 165 12 (2000) 7088-7095
23. Smith S.M., Malin A.S., Pauline T., Lukey, Atkinson S.E., Content J., et al. Characterization of human Mycobacterium bovis bacille Calmette-Guerin-reactive CD8+ T cells. Infect Immun 67 October (10) (1999) 5223-5230
24. Turner J., and Dockrell H.M. Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitro. Immunology 87 3 (1996) 339-342
25. Cho S., Mehra V., Thoma-Uszynski S., Stenger S., Serbina N., Mazzaccaro R.J., et al. Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. Proc Natl Acad Sci USA 97 22 (2000) 12210-12215
26. Skinner M.A., Parlane N., McCarthy A., and Buddle B.M. Cytotoxic T-cell responses to Mycobacterium bovis during experimental infection of cattle with bovine tuberculosis. Immunology 110 October (2) (2003) 234-241
27. Hope J.C., Kwong L.S., Sopp P., Collins R.A., and Howard C.J. Dendritic cells induce CD4+ and CD8+ T-cell responses to Mycobacterium bovis and M. avium antigens in Bacille Calmette Guerin vaccinated and nonvaccinated cattle. Scand J Immunol 52 3 (2000) 285-291
28. Liébana E., Girvin R.M., Welsh M., Neill S.D., and Pollock J.M. Generation of CD8+ T-Cell responses to Mycobacterium bovis and mycobacterial antigen in experimental bovine tuberculosis. Infect Immun 67 3 (1999) 1034-1044
29. Liebana E., Aranaz A., Aldwell F.E., McNair J., Neill S.D., Smyth A.J., et al. Cellular interactions in bovine tuberculosis: release of active mycobacteria from infected macrophages by antigen-stimulated T cells. Immunology 99 January (1) (2000) 23-29
30. Vordermeier H.M., Rhodes S.G., Dean G., Goonetilleke N., Huygen K., Hill A.V., et al. Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guerin. Immunology 112 July (3) (2004) 461-470
31. Machugh N.D., Mburu J.K., Carol M.J., Wyatt C.R., Orden J.A., and Davis W.C. Identification of two distinct subsets of bovine gamma delta T cells with unique cell surface phenotype and tissue distribution. Immunology 92 November (3) (1997) 340-345
32. Akbar A.N., Terry L., Timms A., Beverley P.C., and Janossy G. Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J Immunol 140 April (7) (1988) 2171-2178
33. Michie C.A., McLean A., Alcock C., and Beverley P.C. Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature 360 November (6401) (1992) 264-265
34. Hohn H., Julch M., Pilch H., Kortsik C., Tully G., Neukirch C., et al. Definition of the HLA-A2 restricted peptides recognized by human CD8+ effector T cells by flow-assisted sorting of the CD8+ CD45RA+ CD28- T cell subpopulation. Clin Exp Immunol 131 January (1) (2003) 102-110
35. Jacobsen M., Detjen A.K., Mueller H., Gutschmidt A., Leitner S., Wahn U., et al. Clonal expansion of CD8+ effector T cells in childhood tuberculosis. J Immunol 179 July (2) (2007) 1331-1339
36. Howard C.J., Sopp P., Parsons K.R., McKeever D.J., Taracha E.L., Jones B.V., et al. Distinction of naive and memory BoCD4 lymphocytes in calves with a monoclonal antibody, CC76, to a restricted determinant of the bovine leukocyte-common antigen, CD45. Eur J Immunol 21 September (9) (1991) 2219-2226
37. Stenger S., Hanson D.A., Teitelbaum R., Dewan P., Niazi K.R., Froelich C.J., et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282 5386 (1998) 121-125
38. Andersson J., Samarina A., Fink J., Rahman S., and Grundstrom S. Impaired expression of perforin and granulysin in CD8+ T cells at the site of infection in human chronic pulmonary tuberculosis. Infect Immun 75 November (11) (2007) 5210-5222
39. Garnier T., Eiglmeier K., Camus J.C., Medina N., Mansoor H., Pryor M., et al. The complete genome sequence of Mycobacterium bovis. Proc Natl Acad Sci USA 100 June (13) (2003) 7877-7882
40. Fine P.E.M. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346 8986 (1995) 1339-1345
41. Buddle B.M., Wedlock D.N., Parlane N.A., Corner L.A., De Lisle G.W., and Skinner M.A. Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination. Infect Immun 71 November (11) (2003) 6411-6419
42. Hope J.C., Thom M.L., Villarreal-Ramos B., Vordermeier H.M., Hewinson R.G., and Howard C.J. Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis. Clin Exp Immunol 139 January (1) (2005) 48-56
43. Norimatsu M., Harris J., Chance V., Dougan G., Howard C.J., and Villarreal-Ramos B. Differential response of bovine monocyte-derived macrophages and dendritic cells to infection with Salmonella typhimurium in a low-dose model in vitro. Immunology 108 January (1) (2003) 55-61
44. Taylor G., Thomas L.H., Wyld S.G., Furze J., Sopp P., and Howard C.J. Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves. J Virol 69 November (11) (1995) 6658-6664
45. Bembridge G.P., MacHugh N.D., McKeever D., Awino E., Sopp P., Collins R.A., et al. CD45RO expression on bovine T cells: relation to biological function. Immunology 86 December (4) (1995) 537-544
46. Kwong L.S., Hope J.C., Thom M.L., Sopp P., Duggan S., Bembridge G.P., et al. Development of an ELISA for bovine IL-10. Vet Immunol Immunopathol 85 March (3-4) (2002) 213-223
47. Endsley J.J., Furrer J.L., Endsley M.A., McIntosh M.A., Maue A.C., Waters W.R., et al. Characterization of bovine homologues of granulysin and NK-lysin. J Immunol 173 August (4) (2004) 2607-2614
48. Villarreal-Ramos B., Reed S., McAulay M., Prentice H., Coffey T., Charleston B.C., et al. Influence of the nature of the antigen on the boosting of responses to mycobacteria in M. bovis-BCG vaccinated cattle. Vaccine 24 November (47-48) (2006) 6850-6858
49. MacHugh N.D., Bensaid A., Howard C.J., Davis W.C., and Morrison W.I. Analysis of the reactivity of anti-bovine CD8 monoclonal antibodies with cloned T cell lines and mouse L-cells transfected with bovine CD8. Vet Immunol Immunopathol 27 January (1-3) (1991) 169-172
50. Baldwin C.L., Sathiyaseelan T., Rocchi M., and McKeever D. Rapid changes occur in the percentage of circulating bovine WC1(+)gamma delta Th1 cells. Res Vet Sci 69 October (2) (2000) 175-180
51. Brosch R., Gordon S.V., Garnier T., Eiglmeier K., Frigui W., Valenti P., et al. Genome plasticity of BCG and impact on vaccine efficacy. Proc Natl Acad Sci USA 104 March (13) (2007) 5596-5601
52. Mustafa A.S., Cockle P.J., Shaban F., Hewinson R.G., and Vordermeier H.M. Immunogenicity of Mycobacterium tuberculosis RD1 region gene products in infected cattle. Clin Exp Immunol 130 October (1) (2002) 37-42
53. Vordermeier H.M., Chambers M.A., Cockle P.J., Whelan A.O., Simmons J., and Hewinson R.G. Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect Immun 70 June (6) (2002) 3026-3032
54. Villarreal-Ramos B., McAulay M., Chance V., Martin M., Morgan J., and Howard C.J. Investigation of the role of CD8+ T cells in bovine tuberculosis in vivo. Infect Immun 71 August (8) (2003) 4297-4303
55. Laochumroonvorapong P., Wang J., Liu C.C., Ye W., Moreira A.L., Elkon K.B., et al. Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect Immun 65 January (1) (1997) 127-132